Authors
- Mohamad I. Jarrah, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Ayman J. Hammoudeh, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Dalal B. Al-Natour, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Yousef S. Khader, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Ramzi A. Tabbalat, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Imad A. Alhaddad, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
- Susan M. Kullab, From the Department of Internal Medicine (Jarrah, Kullab), Department of Public Health (Khader), Faculty of Medicine, Jordan University of Science and Technology, Irbid, Department of Cardiology (Hammoudeh), Istishari Hospital, (Tabbalat), Al Khalidi Medical Center, (Alhaddad), Jordan Hospital Medical Center, Pharmaceutical Department (Al-Natour), Jordan Hospital, Amman, Jordan
Abstract
Objectives: To determine the gender differences in cardiovascular risk profile and outcomes among patients undergoing percutaneous coronary intervention (PCI). Methods: In a prospective multicenter study of consecutive Middle Eastern patients managed with PCI from January 2013 to February 2014 in 12 tertiary care centers in Amman and Irbid, Jordan. Clinical and coronary angiographic features, and major cardiovascular events were assessed for both genders from hospital stay to 1 year. Results: Women comprised 20.6% of 2426 enrolled patients, were older (mean age 62.9 years versus 57.2 years), had higher prevalence of hypertension (81% versus 57%), diabetes (66% versus 44%), dyslipidemia (58% versus 46%), and obesity (44% versus 25%) compared with men, p <0.001. The PCI for ST-segment elevation myocardial infarction was indicated for fewer women than men (23% versus 33%; p =0.001). Prevalence of single or multi-vessel coronary artery disease was similar in women and men. More women than men had major bleeding during hospitalization (2.2% versus 0.6%; p =0.003) and at one year (2.5% versus 0.9%; p =0.007). There were no significant differences between women and men in mortality (3.1% versus 1.7%) or stent thrombosis (2.1% versus 1.8%) at 1 year. Conclusion: Middle Eastern women undergoing PCI had worse baseline risk profile compared with men. Except for major bleeding, no gender differences in the incidence of major adverse cardiovascular events were demonstrated.
Article Type
Research Article
Recommended Citation
Jarrah, Mohamad I.; Hammoudeh, Ayman J.; Al-Natour, Dalal B.; Khader, Yousef S.; Tabbalat, Ramzi A.; Alhaddad, Imad A.; and Kullab, Susan M.
(2017)
"Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention,"
Saudi Medical Journal: Vol. 38:
Iss.
2, Article 6.
DOI: https://doi.org/10.15537/smj.2017.2.16301
DOWNLOADS
Since April 09, 2026
COinS